Basagoudanavar S H, Singh D K, Varshney B C
Department of Biochemistry & Molecular Biology, Penn State College of Medicine, Hershey, PA 17033, USA.
J Vet Med A Physiol Pathol Clin Med. 2006 Dec;53(10):524-30. doi: 10.1111/j.1439-0442.2006.00900.x.
The immunoprotective efficacy of Pasteurella multocida (6:B) outer membrane proteins (OMPs) was examined in the mouse model. Bacterial OMPs were extracted using sarkosyl method and analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and immunoblotting. Prototype vaccines were prepared using OMPs with adjuvants including dioleoyl phosphatidyl choline-based liposome and Montanide ISA206 water-in oil-in water emulsion. Antibody response to the vaccine was monitored using indirect enzyme linked immunosorbent assay. The results of the study showed that immunized mice had high titre with both the formulations. The vaccinated mice were able to survive a live virulent bacterial challenge. Based on the findings of the study it can be inferred that OMPs are important determinants of immunoprotection hence can serve as vaccine candidates against haemorrhagic septicaemia.
在小鼠模型中检测了多杀性巴氏杆菌(6:B)外膜蛋白(OMPs)的免疫保护效力。使用十二烷基肌氨酸钠法提取细菌OMPs,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和免疫印迹进行分析。使用OMPs与佐剂(包括基于二油酰磷脂酰胆碱的脂质体和Montanide ISA206水包油包水乳剂)制备原型疫苗。使用间接酶联免疫吸附测定法监测对疫苗的抗体反应。研究结果表明,两种制剂免疫的小鼠均具有高滴度。接种疫苗的小鼠能够在强毒活菌攻击下存活。基于该研究结果可以推断,OMPs是免疫保护的重要决定因素,因此可作为抗出血性败血症的候选疫苗。